Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M. Wardlaw, Martin Dichgans, Ingo Kilimann et al.|The Lancet Neurology|2013Cited by 5.4k
Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaWillemijn J. Jansen, Helmut Hildebrandt, Rik Ossenkoppele et al.|JAMA|2015Cited by 1.6k
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy studyAndreas Charidimou, M. Edip Gurol, Steven M. Greenberg et al.|The Lancet Neurology|2022Cited by 651
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J. Jansen, Lars Frings, Olin Janssen et al.|JAMA Neurology|2022Cited by 281
Operational Definitions for the NINDS-AIREN Criteria for Vascular DementiaElisabeth C.W. van Straaten, Frederik Barkhof, Philip Scheltens et al.|Stroke|2003Cited by 179